销售 更改
AbbVie USD 16.62B 840M 2025-12
ALKERMES USD 384.5M 9.7M 2025-12
Amgen USD 9.9B 340M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Bausch Health Companies USD 2.8B 120M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Cara Therapeutics USD 2.57M 1.11M 2025-03
Coherus Biosciences USD 12.75M 1.18M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Merck USD 16.4B 880M 2025-12
Novartis USD 13.86B 50M 2025-12
Pacira USD 196.87M 17.35M 2025-12
Perrigo USD 1.11B 70M 2025-12
Pfizer USD 17.58B 880M 2025-12
Prestige Brands USD 283.44M 9.34M 2025-12
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
Takeda JPY 1.19T 80B 2025-12
Xeris Pharmaceuticals USD 85.81M 11.43M 2025-12
Zoetis USD 2.4B 0 2025-12